Skip to content

A cohort study of the management and outcomes of patients with metabolic syndrome and related component diseases in Chinese hospitals

A cohort study of the management and outcomes of patients with metabolic syndrome and related component diseases in Chinese hospitals

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082501
Enrollment
Unknown
Registered
2024-03-29
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome and related component diseases

Interventions

NA:NA

Sponsors

West China hospital of Sichuan university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients =18 years of age with MetS and related component diseases (meeting any of the following diagnostic criteria) who were treated at a medical institution: (1) Overweight or central obesity: BMI=22.5 kg/m2, or waist circumference =90cm for men and =85cm for women, or waist-height ratio > 0.5 (2) Diabetes or pre-diabetes: fasting blood glucose =5.6 mmol/L or 2 hours after meals blood glucose > 7.8 mmol/L or HbA1c > 5.7% or diagnosed diabetes (including not used or under treatment with hypoglycemic drugs) (3) Hypertension: systolic blood pressure =130 mmHg or diastolic blood pressure =85 mmHg or being treated with antihypertensive drugs (4) Dyslipidemia: serum TG=150 mg/dL (1.7 mmol/L) or serum HDL-c < 40mg/dL (1.03mmol/L) for men and less than 50mg/dL (1.29mmol/L) for women, or under the treatment of hypolipidemic drugs (5) MAFLD: Liver fat accumulation or fatty liver, as determined by histology or imaging, combined with at least one of the above four conditions (6) Hyperuricemia: In the case of normal purine diet, fasting blood uric acid level exceeds 420µmol/L twice on different days or is receiving drug treatment for hyperuricemia For the retrospective study, the included patients had been followed up at the participating medical institutions for =3 years For prospective studies, included patients were willing to sign the study informed consent

Exclusion criteria

Exclusion criteria: 1 With severe mental illness, end-stage cancer or communication, cognitive dysfunction and other serious health problems. 2. Medical records that are missing or incomplete to the extent that they cannot effectively verify their diagnosis and treatment history will be excluded. 3. Any other circumstances deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

MeasureTime frame
Body weight;blood glucose;blood pressure;blood lipids;

Secondary

MeasureTime frame
liver fat;blood uric acid;

Countries

China

Contacts

Public ContactNanwei Tong

West China hospital of Sichuan university

tongnw@scu.edu.cn+86 189 8060 1196

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026